Magnetic resonance imaging detected additional cancers among women who underwent breast conservation therapy following early diagnosis of breast cancer.
Single-screening MRI found additional cancers among women with a history of breast conservation therapy (BCT), according to a study published in the journal Radiology.
Korean researchers undertook a retrospective study to determine the outcomes of single-screening breast MRI in women who had a history of BCT for breast cancers.
The study group comprised 607 women (median age 48 years) who underwent BCT for breast cancer, had negative mammography and US findings, and underwent subsequent screening breast MR imaging. A total of 557 women (91.8 percent) underwent preoperative MR examinations. The researchers assessed cancer detection rate, characteristics of detected cancers, positive predictive value (PPV), sensitivity, and specificity.
Results showed additional findings by MRI of 11 cancers (eight invasive, three ductal carcinoma in situ) for 18.1 cancers per 1,000 women. The median invasive size was 0.8 cm (range, 0.4–1.4 cm). All were node negative. PPV for recall was 9.4 percent (11 of 117 examinations; PPV for biopsy: 43.5 percent (10 of 23 examinations); sensitivity: 91.7 percent (11 of 12 examinations); and specificity: 82.2 percent (489 of 595 examinations).
“At multivariate analysis, the independent factors associated with women with MR-detected cancers were age younger than 50 years at initial diagnosis and more than a 24-month interval between initial surgery and screening MR imaging,” the authors wrote.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.